Seppic, an Air Liquide Healthcare company, has been a part of the Air Liquide Group since 1986. Seppic specializes in the development, manufacture, and marketing of unique ingredients for a wide range of products including cosmetics, nutraceuticals, pharmaceuticals, veterinary supplies, and industrial applications. Globally, Seppic is comprised of a dedicated team of passionate individuals committed to serving their customers and contributing to the health, well-being, and beauty of all.
While Seppic is involved in various sectors, its expertise in human therapeutic and prophylactic vaccine adjuvants is a crucial part of its healthcare business. Collaborating with clients ranging from academic research institutions to major pharmaceutical companies, Seppic assists in choosing the optimal adjuvant for each vaccine development initiative. The company's expertise in chemistry, formulation, and immunology allows them to produce effective and safe products, thereby contributing to the worldwide endeavor to develop more potent and readily available vaccines.